ATE6511T1 - Antisekretorische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents
Antisekretorische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- ATE6511T1 ATE6511T1 AT79302210T AT79302210T ATE6511T1 AT E6511 T1 ATE6511 T1 AT E6511T1 AT 79302210 T AT79302210 T AT 79302210T AT 79302210 T AT79302210 T AT 79302210T AT E6511 T1 ATE6511 T1 AT E6511T1
- Authority
- AT
- Austria
- Prior art keywords
- het
- hydrogen
- derivatives
- guanidi
- antisecretory
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000001262 anti-secretory effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000001766 1,2,4-oxadiazol-3-yl group Chemical group [H]C1=NC(*)=NO1 0.000 abstract 1
- 125000004515 1,2,4-thiadiazol-3-yl group Chemical group S1N=C(N=C1)* 0.000 abstract 1
- JFINSZHXZPNADJ-UHFFFAOYSA-N 2-[4-(2-aminoethylsulfanylmethyl)-1,3-thiazol-2-yl]guanidine Chemical compound NCCSCC1=CSC(NC(N)=N)=N1 JFINSZHXZPNADJ-UHFFFAOYSA-N 0.000 abstract 1
- -1 3,4-dioxocyclobuten-1, 2-diyl Chemical group 0.000 abstract 1
- 101000989653 Homo sapiens Membrane frizzled-related protein Proteins 0.000 abstract 1
- 102100029357 Membrane frizzled-related protein Human genes 0.000 abstract 1
- JVPQYBYGRCMCGN-UHFFFAOYSA-N N(C(=N)N)C=1SC=C(N1)CSCCNC(=S)NCCSCC=1N=C(SC1)NC(=N)N.C(=S)=S Chemical compound N(C(=N)N)C=1SC=C(N1)CSCCNC(=S)NCCSCC=1N=C(SC1)NC(=N)N.C(=S)=S JVPQYBYGRCMCGN-UHFFFAOYSA-N 0.000 abstract 1
- 125000003435 aroyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002357 guanidines Chemical class 0.000 abstract 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7840704 | 1978-10-16 | ||
| EP79302210A EP0010418B1 (de) | 1978-10-16 | 1979-10-15 | Antisekretorische Guanidinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE6511T1 true ATE6511T1 (de) | 1984-03-15 |
Family
ID=10500369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT79302210T ATE6511T1 (de) | 1978-10-16 | 1979-10-15 | Antisekretorische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US4309435A (de) |
| EP (1) | EP0010418B1 (de) |
| JP (1) | JPS5553279A (de) |
| AT (1) | ATE6511T1 (de) |
| CA (1) | CA1127649A (de) |
| DE (1) | DE2966762D1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO781300L (no) * | 1977-04-20 | 1978-10-23 | Ici Ltd | Fremgangsmaate for fremstilling av fysiologisk aktive guanidinderivater |
| US4309435A (en) * | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| NZ196923A (en) * | 1980-04-29 | 1983-12-16 | Shionogi & Co | 2-guanidino-4-(-acylaminoalkyl(thio)methyl)thiazoles and analogs |
| EP0045155B1 (de) * | 1980-07-30 | 1985-01-02 | Imperial Chemical Industries Plc | Guanidinderivate |
| JPS57102852A (en) * | 1980-12-19 | 1982-06-26 | Shionogi & Co Ltd | Dicarboxylic acid diamide |
| CA1209998A (en) * | 1981-03-09 | 1986-08-19 | David J. Gilman | Amide derivatives as histamine h-2 receptor antagonists |
| CA1233818A (en) * | 1981-03-09 | 1988-03-08 | David J. Gilman | Guanidine derivatives as histamine h-2 receptor antagonists |
| EP0065823A1 (de) * | 1981-05-13 | 1982-12-01 | Imperial Chemical Industries Plc | Heterozyklische Guanidinderivate als Histamin-H-2-Antagonisten |
| US4607105A (en) * | 1981-05-18 | 1986-08-19 | Bristol-Myers Company | 3-cyclobutene-1,2-dione intermediates |
| US4788184A (en) * | 1981-05-18 | 1988-11-29 | Bristol-Myers Company | Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents |
| US4526973A (en) * | 1981-05-18 | 1985-07-02 | Bristol-Myers Company | Chemical compounds |
| US4522943A (en) * | 1981-05-18 | 1985-06-11 | Bristol-Myers Company | Chemical compounds |
| US4503051A (en) * | 1981-05-18 | 1985-03-05 | Bristol-Myers Company | Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use |
| US4539316A (en) * | 1981-05-18 | 1985-09-03 | Bristol-Myers Company | Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones |
| US4546188A (en) * | 1981-05-18 | 1985-10-08 | Bristol-Myers Company | Substituted 1,2-diaminocyclobutene-3,4-diones |
| US4772622A (en) * | 1983-03-25 | 1988-09-20 | Merck & Co., Inc. | 3,5-diamino-1,2,4-oxidiazoles as gastric secretion inhibitors |
| DE3512084A1 (de) * | 1985-04-02 | 1986-10-09 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Guanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US4996221A (en) * | 1987-01-13 | 1991-02-26 | The Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives as immune modulators |
| AU3467493A (en) * | 1992-01-27 | 1993-09-01 | Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives and methods for their use |
| EP4196793A1 (de) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| GB1431589A (en) | 1973-07-13 | 1976-04-07 | Smith Kline French Lab | Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups |
| GB1493931A (en) | 1974-02-07 | 1977-11-30 | Smith Kline French Lab | Guanidines isothioureas and thioureas |
| US4062967A (en) * | 1974-02-07 | 1977-12-13 | Smith Kline & French Laboratories Limited | Bis-guanidino-alkane compounds |
| GB1496787A (en) | 1974-03-12 | 1978-01-05 | Smith Kline French Lab | Heteroalkylthioalkyl amidine derivatives |
| US4093729A (en) * | 1974-06-28 | 1978-06-06 | Smith Kline & French Laboratories Limited | N-Oxy and N-amino guanidines |
| GB1531221A (en) | 1974-09-02 | 1978-11-08 | Smith Kline French Lab | Process for preparing guanidine derivatives |
| MW5076A1 (en) | 1975-12-29 | 1978-02-08 | Smith Kline French Lab | Pharmacologicalle active compounds |
| IL52544A0 (en) * | 1976-07-28 | 1977-10-31 | Smith Kline French Lab | Alpha,omega-bis (heterocyclicguanidino) alkane derivative |
| ZA774221B (en) | 1976-07-28 | 1978-06-28 | Smith Kline French Lab | Pharmacologically active compounds |
| GB1601132A (en) | 1977-03-19 | 1981-10-28 | Smith Kline French Lab | Pharmacologically active triazinones |
| GB1602458A (en) * | 1977-05-05 | 1981-11-11 | Smith Kline French Lab | Bisamidines as histamine h2-antagonists |
| US4233302A (en) * | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
| US4315009A (en) * | 1978-01-18 | 1982-02-09 | Imperial Chemical Industries Limited | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| US4309435A (en) * | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
-
1979
- 1979-10-10 US US06/083,361 patent/US4309435A/en not_active Expired - Lifetime
- 1979-10-15 EP EP79302210A patent/EP0010418B1/de not_active Expired
- 1979-10-15 CA CA337,640A patent/CA1127649A/en not_active Expired
- 1979-10-15 AT AT79302210T patent/ATE6511T1/de not_active IP Right Cessation
- 1979-10-15 DE DE7979302210T patent/DE2966762D1/de not_active Expired
- 1979-10-16 JP JP13248879A patent/JPS5553279A/ja active Pending
-
1981
- 1981-10-26 US US06/314,558 patent/US4493840A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4309435A (en) | 1982-01-05 |
| EP0010418A1 (de) | 1980-04-30 |
| EP0010418B1 (de) | 1984-03-07 |
| DE2966762D1 (en) | 1984-04-12 |
| US4493840A (en) | 1985-01-15 |
| CA1127649A (en) | 1982-07-13 |
| JPS5553279A (en) | 1980-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE6511T1 (de) | Antisekretorische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ES474929A1 (es) | Procedimiento para preparar un derivado de guanidina. | |
| KR840008016A (ko) | 융합 이미다졸 화합물의 제조방법 | |
| KR940000447A (ko) | 티아졸의 분지쇄 알킬아미노유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물 | |
| DE2963363D1 (en) | Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them | |
| ATE32064T1 (de) | Substituierte 2-mercapto-imidazole und deren herstellung und anwendung. | |
| JPS646270A (en) | Pyridine derivative and remedy for ulceration containing the same | |
| DE2966030D1 (en) | Antisecretory heterocyclic guanidine derivatives, process for their manufacture and pharmaceutical compositions containing them | |
| DE2966646D1 (en) | Antisecretory branched-chain heterocyclic guanidine derivatives, processes for their manufacture, intermediates, and pharmaceutical compositions containing said derivatives | |
| HUT40118A (en) | Process for preparing 5-/azolyl-oxy-phenyl-carbamoyl/-barbituric acid-derivatives | |
| KR880701231A (ko) | N-(2-치환된 알킬)-n'-((이미다졸-4-일)알킬) 구 아니딘 | |
| KR840001177A (ko) | 제초제인 설폰아미드의 제조방법 | |
| ES482448A1 (es) | Procedimiento para preparar pirimidinas. | |
| DE3378467D1 (en) | Process for preparing 5-perfluoroalkyl-5,6-dihydrouracil derivatives and compounds for use therein | |
| KR840006342A (ko) | 복소환식 화합물 및 그 제법 | |
| NZ240404A (en) | Oxysulphonyl (thio)carbamate derivatives and pharmaceutical | |
| GB1396858A (en) | Heterocyclic-substituted 1,3,4-thiadiazole derivatives process for their preparation and their use as herbicides | |
| JPS5576872A (en) | Imidazolidinone derivative | |
| KR900016201A (ko) | 디아진 유도체와 그 제조방법 및 이를 함유하는 약제 | |
| KR830009047A (ko) | 4-(5)-알킬메르캅토이미다졸 유도체의 제조방법 | |
| CY1742A (en) | Mitomycin analogs a process for preparing them and pharmaceutical compositions | |
| GB1068035A (en) | ª-(substituted-thio) (acylphenoxy and acylphenylmercapto) acetic acids | |
| JPS56115780A (en) | Phenoxyalkaneacid derivative substituted by heterocyclic ring containing nitrogen and sulfur, and its preparation | |
| ES443046A1 (es) | Procedimiento para la preparacion de derivados de la tiou- rea. | |
| GB1435376A (en) | Benzimidazolyl isothiocyanates methods for their preparation and compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |